JSW Energy Fund Raise of ₹4,000 Cr

JSW Energy Employee Stock Options

JSW Energy's employee welfare trust transferred 10,044 shares to employees after ESOP option exercises. The off-market transfer was valued at about Rs 0.01 Crore.

Value

₹0.01 Cr

JSW Energy Management Change

JSW Energy appointed Chandrasekaran Prabhakaran as Executive Director (Whole-time Director) on 28 October 2026. He brings over 26 years of corporate finance and governance experience.

JSW Energy Q2 FY27 Results: Net Profit ₹1,141 Cr, Up 38.4% YoY

JSW Energy Ltd reported revenue from operations of ₹6,368 Cr (+23.0% YoY) and net profit of ₹1,141 Cr (+38.4% YoY) for Q2 FY27.

Key figure

Net profit ₹1,141 Cr · +38.4% YoY

JSW Energy Credit Rating

JSW Energy disclosed ICRA's assignment of A(Stable)/A2+ ratings to three step-down wholly owned subsidiaries. The ratings cover their long-term bank facilities, dated 23 October 2026.

JSW Energy Earnings Call Transcript: Key Takeaways

JSW Energy delivered record capacity additions but faced significant hydrology headwinds and one-off transmission issues.

JSW Energy Board Meeting Date

JSW Energy has scheduled its Board meeting for 28 October 2026 to consider Q1 results, NCD issuance, and equity fundraising. The trading window reopens on 31 October 2026.

Rite Zone Chemcon India Fund Raise of ₹6.58 Cr

Rite Zone Chemcon India announced a preferential issue of 27,69,730 equity shares to 11 investors at Rs.24 each, raising about Rs.6.58 Crore. The approval awaits a shareholder vote on 23 November 2026.

Value

₹6.58 Cr

Sudarshan Pharma Industries Fund Raise of ₹72 Cr

Sudarshan Pharma's board approved up to Rs. 72 Crore of preferential convertible warrants for promoters Hemal and Sachin Mehta. Shareholder approval will be sought at an EGM.

Value

₹72.00 Cr

Flywings Simulator Training Centre Fund Raise of ₹68.2 Cr

Flywings Simulator's board approved Rs. 68.20 Crore fully convertible warrants on a preferential basis. Promoter Rupal Mandavia is allotted Rs. 25 Crore, subject to shareholder approval.

Value

₹68.20 Cr

Kanel Industries Fund Raise of ₹16.99 Cr

Kanel Industries' board approved a rights issue of 42.52 lakh equity shares at Rs.39.95 each. The issue aggregates about Rs.16.99 Crore, with record date 13 November 2026.

Value

₹16.99 Cr

Execution

Rights issue opens 23 November 2026 and closes 30 November 2026

Sudarshan Pharma Industries Fund Raise

Board approved issuing up to 72 Crore warrants to promoters on a preferential basis. Pricing per Reg 164 is pending, with no fixed rupee value stated.

GAIL (India) Fund Raise

GAIL Board approved in principle the IPO of subsidiary GAIL Gas Limited on Indian exchanges. GAIL will dilute its GGL equity up to 25%.